Rational therapy of mixed dyslipidaemia in a patient with diabetes

Charles Reasner

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Diabetic dyslipidaemia refers to the triad of elevated levels of triglycerides and small, dense LDL-C particles and low levels of HDL-C. These lipid abnormalities are largely responsible for the increased risk of cardiovascular complications in patients with diabetes. This case study outlines a rational approach to the treatment of each of these lipid abnormalities and emphasises the importance of both lowering the LDL-C and raising the HDL-C in high-risk individuals. Combination drug therapy will often be necessary to achieve treatment goals in these patients.

Original languageEnglish (US)
Pages (from-to)25-30
Number of pages6
JournalBritish Journal of Diabetes and Vascular Disease
Volume7
Issue number1
DOIs
StatePublished - Jan 2007

Fingerprint

Dyslipidemias
Lipids
Combination Drug Therapy
Triglycerides
Therapeutics
oxidized low density lipoprotein

Keywords

  • Atherogenic dyslipidaemia
  • Diabetes
  • Diabetic dyslipidaemia
  • Fibrates
  • Niacin
  • Statins

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Rational therapy of mixed dyslipidaemia in a patient with diabetes. / Reasner, Charles.

In: British Journal of Diabetes and Vascular Disease, Vol. 7, No. 1, 01.2007, p. 25-30.

Research output: Contribution to journalArticle

@article{f4d92dbb7bce4cf6b4f7f301055c2867,
title = "Rational therapy of mixed dyslipidaemia in a patient with diabetes",
abstract = "Diabetic dyslipidaemia refers to the triad of elevated levels of triglycerides and small, dense LDL-C particles and low levels of HDL-C. These lipid abnormalities are largely responsible for the increased risk of cardiovascular complications in patients with diabetes. This case study outlines a rational approach to the treatment of each of these lipid abnormalities and emphasises the importance of both lowering the LDL-C and raising the HDL-C in high-risk individuals. Combination drug therapy will often be necessary to achieve treatment goals in these patients.",
keywords = "Atherogenic dyslipidaemia, Diabetes, Diabetic dyslipidaemia, Fibrates, Niacin, Statins",
author = "Charles Reasner",
year = "2007",
month = "1",
doi = "10.1177/14746514070070010501",
language = "English (US)",
volume = "7",
pages = "25--30",
journal = "British Journal of Diabetes and Vascular Disease",
issn = "1474-6514",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Rational therapy of mixed dyslipidaemia in a patient with diabetes

AU - Reasner, Charles

PY - 2007/1

Y1 - 2007/1

N2 - Diabetic dyslipidaemia refers to the triad of elevated levels of triglycerides and small, dense LDL-C particles and low levels of HDL-C. These lipid abnormalities are largely responsible for the increased risk of cardiovascular complications in patients with diabetes. This case study outlines a rational approach to the treatment of each of these lipid abnormalities and emphasises the importance of both lowering the LDL-C and raising the HDL-C in high-risk individuals. Combination drug therapy will often be necessary to achieve treatment goals in these patients.

AB - Diabetic dyslipidaemia refers to the triad of elevated levels of triglycerides and small, dense LDL-C particles and low levels of HDL-C. These lipid abnormalities are largely responsible for the increased risk of cardiovascular complications in patients with diabetes. This case study outlines a rational approach to the treatment of each of these lipid abnormalities and emphasises the importance of both lowering the LDL-C and raising the HDL-C in high-risk individuals. Combination drug therapy will often be necessary to achieve treatment goals in these patients.

KW - Atherogenic dyslipidaemia

KW - Diabetes

KW - Diabetic dyslipidaemia

KW - Fibrates

KW - Niacin

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=33947215569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947215569&partnerID=8YFLogxK

U2 - 10.1177/14746514070070010501

DO - 10.1177/14746514070070010501

M3 - Article

AN - SCOPUS:33947215569

VL - 7

SP - 25

EP - 30

JO - British Journal of Diabetes and Vascular Disease

JF - British Journal of Diabetes and Vascular Disease

SN - 1474-6514

IS - 1

ER -